US Court Orders Health Risk Warnings on Cigarettes in Retail Stores

Dec.08.2022
US Court Orders Health Risk Warnings on Cigarettes in Retail Stores
US court orders cigarette companies to display health risk labels and corrective statements in retail stores.

A US court has ordered tobacco companies to display health warning labels related to smoking in retail stores. On December 6, the US Department of Justice announced a court order requiring tobacco companies to display health warning labels in retail stores and to issue corrective statements regarding the health risks and addictive properties of cigarettes.


In a press release on Tuesday, the Department of Justice stated that the court order "resolved the government's long-standing civil extortion lawsuit against the largest tobacco company in the United States.


In 1999, a lawsuit was filed in the United States. The trial took place in the District Court of Washington D.C. between 2004 and 2005, with the court ruling that these companies had misled consumers regarding the health risks of smoking.


Since 2019, tobacco use among teenagers has decreased from 6 million to 3 million.


The court order applies to four cigarette brands owned by Altria, Philip Morris USA Inc., R.J.Reynolds Tobacco Company and ITG Brands LLC.


A new study from San Diego State University predicts that "heat-not-burn" tobacco products could soon dominate the US market.


The Deputy Attorney General, Vanita Gupta, stated that lawyers at the Department of Justice have been working tirelessly for over 20 years to hold tobacco companies accountable for deceiving consumers about the health risks of smoking. The resolution enforces the remedies of the lawsuit to ensure consumers are aware of the hazards of purchasing tobacco products.


It is estimated that out of the 300,000 retail stores selling cigarettes in the United States, 200,000 have entered into agreements with tobacco companies to display health warning labels on their tobacco products in the stores.


According to an order released on December 6th, companies are required to modify their agreements with retail stores and display correction statements in stores. These statements will be marked with colorful logos and designed to catch attention, while also highlighting information such as the negative health effects of smoking, the addictive nature of nicotine, and the harmful effects of secondhand smoke.


This directive will come into effect on July 1, 2023, and these companies will have a three-month window to make necessary changes. After that, retailers will be required to display signs in both English and Spanish for a period of 21 months.


William Klein, Deputy Director of the "Behavioral Research" project at the National Cancer Institute, called this a momentous occasion in the history of cancer control in the United States. Smoking accounts for approximately 30% of all cancer deaths in the country. Therefore, the corrective statements ordered by the court to be displayed at tobacco sales points will help support our mission of reducing the burden of cancer. We are grateful to our colleagues in the Department of Justice for completing this important work.


2FIRSTS will continue to report on this issue and future updates will be available on the "2FIRSTSAPP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
JT Plans ¥800 Billion Investment in Heated Tobacco Over Three Years, Betting on Ploom as Second Growth Engine
JT Plans ¥800 Billion Investment in Heated Tobacco Over Three Years, Betting on Ploom as Second Growth Engine
Japan Tobacco Inc. (JT) CEO Takehiko Tsutsui said the company plans to invest about ¥800 billion (approximately US$5.4 billion) in heated tobacco products over three years through 2028, aiming to establish Ploom as a second growth engine after combustible cigarettes. Tsutsui said Ploom AURA helped JT increase its share of Japan’s heated tobacco market to 15.8% in the first quarter of 2026. Ploom products are now available in 29 markets, with Ploom AURA sold in 25 markets including Japan. JT also plans to continue its cigarette business while positioning its food operations, particularly frozen noodle products in North America, as another growth opportunity.
Jul.23
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
ITC Infotech has expanded its multi-year strategic technology partnership with British American Tobacco (BAT), providing technology services across Poland, Romania and India while continuing to support BAT's newly launched Future Capabilities Centre in India and existing technology hubs in Malaysia and Mexico. The companies said the agreement will focus on AI-enabled innovation, technology capability building and greater operational efficiency. The partnership also aligns with BAT's broader Fit2Win transformation programme, under which the group is expanding the use of external technology and business-services partners to simplify its global operating model.
Aug.13
Reemtsma says German illegal e-cigarette seizures reached 70% of 2025 total, pouches 179%
Reemtsma says German illegal e-cigarette seizures reached 70% of 2025 total, pouches 179%
Reemtsma said its first-half 2026 black-market tracker for tobacco and nicotine products showed a continued rise in officially reported seizures in Germany, with illegal e-cigarette seizures reaching 70% of the full-year 2025 level and snus and nicotine pouch seizures reaching 179% of last year’s total.
Jul.08
UK Vape Brands Face White-Packaging and Flavour-Name Curbs in Youth-Appeal Crackdown
UK Vape Brands Face White-Packaging and Flavour-Name Curbs in Youth-Appeal Crackdown
The UK government and devolved administrations have launched a 12-week consultation on proposals to make vapes less appealing to children, including plain white packaging, limits on device colours, restrictions on flavour names and changes to how products are displayed in shops.
Jul.10
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26